Samples were then mixed with 20 pmol of RNase A substrate and 10 L of 10 RNaseAlert Buffer and incubated in RNase-free black 96-well microplates (Fisher) at 37 C for 30 min. its C terminus. The revised YebF protein was indicated in cells transporting the Im7 as the POI for a number of reasons: 1) it is a small, globular 87-residue Mitoquinone mesylate protein that lacks disulfide bonds and is well-expressed in the periplasm where bacterial Mitoquinone mesylate (25); 3) crystal constructions are available for wild-type (wt) Im7 (26) and for Im7 in complex with its cognate toxin colicin E7 (ColE7) (27); and 4) a limited set of seven Im7 variants was previously generated to determine the effects of GlcNAc2 attachment on folding and stability (22), providing some useful research points for assessment. Open in a separate windowpane Fig. 2. Building and interrogation of SSGM libraries. Rabbit polyclonal to TDT (strain CLM24 along with two additional plasmids encoding the requisite CLM24 transporting a plasmid encoding either YebF-Im7 or YebF-Im7DQNAT along with plasmids encoding but with YebF-RNase A and YebF-RNase AN34 in colony secretions (and depict overlay of -His and SBA blots (merge). Arrows denote aglycosylated (g0) and singly glycosylated (g1) forms of YebF-Im7DQNAT or YebF-RNase AN34. Molecular excess weight (strain CLM24 was transformed having a plasmid encoding YebF-Im7 that was revised having a DQNAT glycosylation tag (28) in the C terminus of Im7 along with two additional plasmids, one encoding glycosyltransferase (GT) enzymes for the biosynthesis of the from the OST PglB (cells, as well as its compatibility with PglB, all help to ensure that variations in glycosylation effectiveness are minimally affected by substrate-related factors and are instead attributable to convenience of a given acceptor site. When plated on solid agar and subjected to the colony-blotting method, cells expressing YebF-Im7DQNAT, or a control YebF-Im7 construct that lacked the glycosylation tag, were able to secrete the fusion into the extracellular medium as evidenced by cross-reaction of an anti-His antibody with the membranes (Fig. 2Im7 immunity protein. Asterisks denote location and rate of recurrence of glycosite hits isolated using SSGM. Predicted structures adapted from Protein Data Standard bank (PDB) ID code 1AYI. (and indicate the activity and and using two-way ANOVA with significance indicated as follows: *< 0.1; **< 0.01; ***< 0.001; ****< 0.0001; unmarked, not significant. To exhaustively explore glycosylation sequence space, we constructed all possible individual Im7 sequon variants (80 in total) using the multiplex PCR primer pairs to expose DQNAT sequons at every position of the protein. A strikingly large number (78 out of 80) of these variants were found to be glycosylated, many with an effectiveness that was at or near 100% as estimated from densitometry of the anti-His blot (Fig. 3and and glycosylation machinery were transformed with the SSGM library and subjected to glycoSNAP screening. A total of 100 glycosylation-positive colonies were randomly selected from two membranes and subjected to sequencing analysis. Of these, only 50 were nonredundant as many of the sequences were isolated multiple instances (e.g., seven instances each for RNase AN41 and RNase AN122; Fig. 4and and and show the activity and and using two-way ANOVA with significance indicated as follows: *< 0.1; **< 0.01; ***< 0.001; ****< 0.0001; unmarked, not significant. To investigate whether the structural context of the sequon impacted the possible timing of PglB-mediated glycan installation, we performed cell-free glycosylation of folded RNase A variants. While some variants were glycosylated equally well in cell-based and cell-free reactions (e.g., RNase AN46 Mitoquinone mesylate and RNase AN64), an unexpectedly large number showed significantly lower levels of glycosylation under cell-free conditions (Fig. 4and and and glycosylation machinery. A total of 60 dual-positive hits were isolated from membranes, of which 21 were determined to be nonredundant (e.g., N58 in VL and N42 in VH were each isolated.
Samples were then mixed with 20 pmol of RNase A substrate and 10 L of 10 RNaseAlert Buffer and incubated in RNase-free black 96-well microplates (Fisher) at 37 C for 30 min